Monday, May 21, 2018
 
 
Company News: Page (1) of 1 - 04/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
One Drop Direct-to-Consumer Subscriptions Lower A1c By 1.9% In 3 Months
One Drop announces study results demonstrating a 1.9% reduction in eA1c in just 3 months among people with type 2 diabetes using One Drop's direct-to-consumer digital therapeutics solution
(April 13, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Communications,Web,Smart Phone,Search,Google,Insurance,Health Care,Education,Internet,Business Issues,Management,CEO/CFO,Mac,Android,USA,Science,Communications Technology,Medical,Science,
Related Sites: Creative Mac ,   AEC Newsroom ,   Audio Video Producer ,   Corporate Media News ,   DMN Newswire ,   CEN - Consumer Electronics Net ,   CEN - Phones ,   itbusinessnet.com ,   IBN - Business ,   IBN - Internet ,   CEN - Web ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Digital Media Net ,   DMNForums ,   CEN - Gadgets Newsletter ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
  • Regenerative Medicine Market Analysis Study Found Huge Boom By Rising Prevalence Of Chronic Diseases And Genetic Disorders Till 2025: Grand View Research,Inc.
  • Global Molecular Diagnostics Markets, 2016-2024 - Focus on Infectious Disease Testing, Blood Screening, Cancer Screening & Other Applications
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Strategic Business Report 2018
  • Global Sleep Apnea Diagnostic and Therapeutic Devices: 2016/18-2024 Strategic Business Analysis & Forecast Report - mHealth-Enabled Sleep Tracking Devices Gain Ground

    Cancer
  • Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
  • Altogen Labs xenograft services for drug development studies of anti-cancer therapeutics
  • HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
  • Dr. Haydee Gonzalez Hidalgo joins The Oncology Institute of Hope and Innovation
  • eClinical Solutions Market Size Is Projected To Reach $13 Billion By 2024
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines